AMOEBA (EPA:ALMIB) | WebDisclosure

Basculer en Français

9480	Companies
185562	Keywords
117963	Articles
99396	Press releases

Home
Companies
AMOEBA

PRESS RELEASE

published on 11/25/2024 at 17:45, 1 year ago

Lutte contre le mildiou en vigne : Des essais montrent l'efficacité du produit de biocontrôle AXPERA sur le mildiou de la vigne dans des conditions difficiles en 2024
Amoéba annonce le succès de son essai sur le mildiou de la vigne avec son nouveau biofongicide AXPERA en partenariat avec IFV+, offrant une solution durable aux viticulteurs français

AMOEBA Viticulture AXPERA Biofongicide Mildiou
PRESS RELEASE

published on 11/25/2024 at 17:45, 1 year ago

Combating downy mildew in vines: Trials show the effectiveness of the biocontrol product AXPERA on downy mildew in vines under difficult conditions in 2024
Amoéba and IFV+ successfully tested AXPERA, a new amoeba lysate-based biofungicide, against downy mildew in vines in south-west France. AXPERA shows promising effectiveness in reducing fungal disease symptoms

AMOEBA Biofungicide AXPERA IFV+ Downy Mildew
BRIEF

published on 11/21/2024 at 17:50, 1 year ago

Amoéba publie un article sur son innovation cosmétique

AMOEBA Innovation Cosmétique Lysat De Willaertia Vieillissement Cutané
BRIEF

published on 11/21/2024 at 17:50, 1 year ago

Amoéba publishes an article on its cosmetic innovation

AMOEBA Innovation Cosmetic Willaertia Lysate Skin Aging
PRESS RELEASE

published on 11/21/2024 at 17:45, 1 year ago

Amoéba annonce la publication d'un premier article scientifique sur l'efficacité de son innovation en cosmétique
Amoéba, greentech française, publie un article scientifique sur l'efficacité de son lysat de Willaertia dans le journal Cosmetics. Les données montrent une amélioration de la cicatrisation, de la pigmentation et une réduction des signes du vieillissement cutané

AMOEBA Cosmétique GreenTech Lysat De Willaertia Vieillissement Cutané
PRESS RELEASE

published on 11/21/2024 at 17:45, 1 year ago

Amoéba announces the publication of a first scientific article on the efficacy of its innovation in cosmetics
Amoéba announces publication of a scientific article on the efficacy of Willaertia lysate in Cosmetics journal. Discover the natural microbiological solution's benefits for skin anti-aging

AMOEBA Willaertia Lysate Cosmetics Journal Skin Anti-aging Microbiological Solution
BRIEF

published on 10/07/2024 at 17:50, 1 year 1 month ago

Amoéba Publie son Rapport Financier Semestriel au 30 Juin 2024

AMOEBA Biocontrôle Cosmétique Rapport Financier Investisseurs
BRIEF

published on 10/07/2024 at 17:50, 1 year 1 month ago

Amoéba Publishes its Half-Yearly Financial Report as of June 30, 2024

AMOEBA Investors Financial Report Biocontrol Cosmetic
PRESS RELEASE

published on 10/07/2024 at 17:45, 1 year 1 month ago

Amoéba : Mise à disposition du rapport financier semestriel au 30 juin 2024
Amoéba, société greentech basée à Chassieu, publie son rapport financier semestriel au 30 juin 2024 et annonce un prochain séminaire Biotech & Santé. En savoir plus sur amoeba-nature.com

AMOEBA Biotech Rapport Financier GreenTech Séminaire
PRESS RELEASE

published on 10/07/2024 at 17:45, 1 year 1 month ago

Amoéba: Publication of the half-year financial report at 30 June 2024
Amoéba announces the publication of its half-year financial report for 2024 and upcoming institutional investor event. Amoéba, a greentech company, provides natural microbiological solutions

AMOEBA Investor Event Half-year Financial Report GreenTech Microbiological Solutions

Accesswire

Published on 12/05/2025 at 23:30, 36 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:50, 1 hour 16 minutes ago

Banyan Gold Grants Incentive Stock Options
Published on 12/05/2025 at 21:45, 2 hours 21 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 2 hours 36 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 2 hours 46 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 1 hour 50 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 1 hour 53 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 5 hours 7 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 5 hours 39 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 5 hours 50 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 1 hour 6 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 6 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 6 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 1 hour 6 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 6 hours 48 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE